Literature DB >> 8174561

Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1.

J Freund1, R Kellner, T Houthaeve, H R Kalbitzer.   

Abstract

Proteolytic experiments in conjunction with 1H-NMR spectroscopy show that the Nef (negative factor) protein from human immunodeficiency virus type 1 probably consists of two main domains, the N-terminal anchor domain at amino acid positions 2-65 and the C-terminal core domain at positions 66-206. The N-terminal domain is likely to be located at the surface of the protein, while the C-terminal domain has a compactly folded core and is stable in the absence of the anchor domain. It is conceivable that the core domain represents a functional domain of the Nef protein, activated after the removal of the membrane anchor by the human-immunodeficiency-virus protease or cellular proteases. Nef is stable at pH 5-12 and denatures at 317-322 K. The Nef protein remains in its native conformation in dimethyl-sulfoxide/water mixtures up to 35% (by vol.), and in acetonitrile/water up to 14% (by vol.). Nef refolds spontaneously after denaturation with urea or guanidinium hydrochloride. The 1H-NMR parameters and pKa values of five of the nine histidine residues and one of the seven tyrosine residues were determined and were found in four cases to be typical for residues which are not located in the interior of the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174561     DOI: 10.1111/j.1432-1033.1994.tb18795.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  HIV-1 Nef protein: purification, crystallizations, and preliminary X-ray diffraction studies.

Authors:  P Franken; S Arold; A Padilla; M Bodeus; F Hoh; M P Strub; M Boyer; M Jullien; R Benarous; C Dumas
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

2.  Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases.

Authors:  J Schorr; R Kellner; O Fackler; J Freund; J Konvalinka; N Kienzle; H G Kräusslich; N Mueller-Lantzsch; H R Kalbitzer
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Refined solution structure and backbone dynamics of HIV-1 Nef.

Authors:  S Grzesiek; A Bax; J S Hu; J Kaufman; I Palmer; S J Stahl; N Tjandra; P T Wingfield
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

Review 4.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

5.  Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein.

Authors:  S Arold; F Hoh; S Domergue; C Birck; M A Delsuc; M Jullien; C Dumas
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

6.  Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.

Authors:  M W Pandori; N J Fitch; H M Craig; D D Richman; C A Spina; J C Guatelli
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Regions of human immunodeficiency virus type 1 nef required for function in vivo.

Authors:  G M Aldrovandi; L Gao; G Bristol; J A Zack
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity.

Authors:  R Welker; M Harris; B Cardel; H G Kräusslich
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  A novel dimer-tetramer transition captured by the crystal structure of the HIV-1 Nef.

Authors:  Pankaj Singh; Gaya Prasad Yadav; Sudeepti Gupta; Anil Kumar Tripathi; Ravishankar Ramachandran; Raj Kamal Tripathi
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

10.  In-silico designing of a potent analogue against HIV-1 Nef protein and protease by predicting its interaction network with host cell proteins.

Authors:  Shikha Pal; Madhur Mishra; D Raja Sudhakar; Mohammed Haris Siddiqui
Journal:  J Pharm Bioallied Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.